
China Biologic Products Holdings, Inc. CBPO
China Biologic Products Holdings, Inc. DSO | CBPO
DSO Jährlich China Biologic Products Holdings, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 106 | 72.7 | 97.8 | 121 | 36.3 | 31 | 29.1 | 31 | 22.1 | 46.1 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 121 | 22.1 | 59.3 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Sangamo Therapeutics
SGMO
|
4.14 | - | - | $ 50.4 M | ||
|
Salarius Pharmaceuticals
SLRX
|
382 | - | - | $ 2.64 M | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
3.86 | - | - | $ 826 K | ||
|
Vaxart
VXRT
|
101 | - | -25.06 % | $ 46.3 M | ||
|
XOMA Corporation
XOMA
|
23.6 | - | - | $ 485 M | ||
|
Repare Therapeutics
RPTX
|
16.7 K | - | - | $ 112 M | ||
|
Sesen Bio
SESN
|
391 | - | 7.29 % | $ 127 M | ||
|
Windtree Therapeutics
WINT
|
93.6 | - | - | $ 26.8 M | ||
|
SQZ Biotechnologies Company
SQZ
|
25.5 | - | 57.95 % | $ 12.8 M | ||
|
MEI Pharma
MEIP
|
392 | - | 10.43 % | $ 20.5 M | ||
|
Palatin Technologies
PTN
|
6.22 | - | - | $ 13 M | ||
|
Brickell Biotech
BBI
|
26 | - | -5.38 % | $ 6.06 M | ||
|
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
107 | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
18.6 | - | - | $ 5.78 B | ||
|
AbbVie
ABBV
|
258 | $ 293.87 | 0.19 % | $ 520 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
43.3 | $ 151.6 | -3.2 % | $ 19.9 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
33.4 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Axon Enterprise
AXON
|
134 | $ 302.6 | -0.19 % | $ 23.6 B | ||
|
Theratechnologies
THTX
|
82.9 | - | - | $ 83.9 M | ||
|
Liquidia Corporation
LQDA
|
65.5 | $ 51.37 | 7.31 % | $ 4.42 B | ||
|
CRISPR Therapeutics AG
CRSP
|
1.3 K | $ 45.05 | -9.97 % | $ 4.05 B | ||
|
Scholar Rock Holding Corporation
SRRK
|
445 | $ 48.48 | -5.96 % | $ 5.56 B | ||
|
Geron Corporation
GERN
|
636 | $ 0.96 | -3.71 % | $ 640 M | ||
|
Bristol-Myers Squibb Company
BMY
|
83.9 | $ 62.8 | 1.06 % | $ 128 B | ||
|
Titan Pharmaceuticals
TTNP
|
81.3 | - | -3.76 % | $ 3.47 M | ||
|
Kazia Therapeutics Limited
KZIA
|
28.7 | $ 7.4 | -0.13 % | $ 113 M | ||
|
Celldex Therapeutics
CLDX
|
321 | $ 30.68 | -1.81 % | $ 2.04 B | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
11.6 | $ 4.0 | -6.76 % | $ 48.8 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
66.7 | $ 317.26 | 0.99 % | $ 6.14 B | ||
|
Eli Lilly and Company
LLY
|
80.5 | $ 1 432.7 | 1.47 % | $ 1.29 T | ||
|
Crinetics Pharmaceuticals
CRNX
|
211 | $ 84.95 | 0.13 % | $ 7.99 B |